StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.78−1.10 (-5.03%)

Close on Nov 17, 2026Market cap $1.44BP/E –Yield –

uniQure ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

uniQure's ebitda for the twelve months ending Jun 30, 2026 was -$185.61M. For fiscal 2025 it was -$170.59M. The highest annual figure on record is $317.92M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$170.59M–
FY2024Dec 31, 2024-$171.65M–
FY2023Dec 31, 2023-$270.97M–
FY2022Dec 31, 2022-$134.62M-142.3%
FY2021Dec 31, 2021$317.92M–
FY2020Dec 31, 2020-$114.78M–
FY2019Dec 31, 2019-$114.47M–
FY2018Dec 31, 2018-$75.82M–
FY2017Dec 31, 2017-$63.80M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$47.30M–
Q1 FY2026Mar 31, 2026-$42.76M–
Q4 FY2025Dec 31, 2025-$48.15M–
Q3 FY2025Sep 30, 2025-$47.40M–
Q2 FY2025Jun 30, 2025-$40.24M–
Q1 FY2025Mar 31, 2025-$34.80M–
Q4 FY2024Dec 31, 2024-$41.47M–
Q3 FY2024Sep 30, 2024-$37.24M–
Q2 FY2024Jun 30, 2024-$41.34M–
Q1 FY2024Mar 31, 2024-$51.60M–
Q4 FY2023Dec 31, 2023-$57.56M-299.6%
Q3 FY2023Sep 30, 2023-$79.28M–
Q2 FY2023Jun 30, 2023-$62.49M–
Q1 FY2023Mar 31, 2023-$71.65M–
Q4 FY2022Dec 31, 2022$28.83M+635.5%
Q3 FY2022Sep 30, 2022-$57.42M–
Q2 FY2022Jun 30, 2022-$54.08M-113.5%
Q1 FY2022Mar 31, 2022-$51.96M–
Q4 FY2021Dec 31, 2021$3.92M–
Q3 FY2021Sep 30, 2021-$43.22M–
Q2 FY2021Jun 30, 2021$399.81M–
Q1 FY2021Mar 31, 2021-$42.60M–
Q4 FY2020Dec 31, 2020-$5.97M–
Q3 FY2020Sep 30, 2020-$39.64M–
Q2 FY2020Jun 30, 2020-$36.44M–
Q1 FY2020Mar 31, 2020-$32.73M–
Q4 FY2019Dec 31, 2019-$31.24M–
Q3 FY2019Sep 30, 2019-$29.61M–
Q2 FY2019Jun 30, 2019-$27.68M–
Q1 FY2019Mar 31, 2019-$25.94M–
Q4 FY2018Dec 31, 2018-$22.24M–
Q3 FY2018Sep 30, 2018-$15.99M–
Q2 FY2018Jun 30, 2018-$19.54M–
Q1 FY2018Mar 31, 2018-$18.05M–
Q2 FY2017Jun 30, 2017-$17.25M–
Q1 FY2017Mar 31, 2017-$17.92M–

More uniQure figures

See a number that looks wrong?